25 XP   0   0   10

Nanjing Well Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Nanjing Well Pharmaceutical Co Ltd together

PenkeI guess you are interested in Nanjing Well Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nanjing Well Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Nanjing Well Pharmaceutical Co Ltd

I send you an email if I find something interesting about Nanjing Well Pharmaceutical Co Ltd.

Quick analysis of Nanjing Well Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Nanjing Well Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.21
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥10.94
Expected worth in 1 year
¥13.81
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥4.40
Return On Investment
18.2%

For what price can you sell your share?

Current Price per Share
¥24.13
Expected price per share
¥20.03 - ¥27.88
How sure are you?
50%

1. Valuation of Nanjing Well Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥24.13

Intrinsic Value Per Share

¥-22.35 - ¥-15.91

Total Value Per Share

¥-11.41 - ¥-4.97

2. Growth of Nanjing Well Pharmaceutical Co Ltd (5 min.)




Is Nanjing Well Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$204.5m$191.1m$13.3m6.5%

How much money is Nanjing Well Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$13.1m$13.9m-$875.1k-6.7%
Net Profit Margin8.6%9.7%--

How much money comes from the company's main activities?

3. Financial Health of Nanjing Well Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Nanjing Well Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Nanjing Well Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Nanjing Well Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Nanjing Well Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Nanjing Well Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Nanjing Well Pharmaceutical Co Ltd is ¥24.13. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nanjing Well Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nanjing Well Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥10.94. Based on the TTM, the Book Value Change Per Share is ¥0.72 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.63 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.38 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nanjing Well Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.100.4%0.100.4%0.100.4%0.110.5%0.110.4%
Usd Book Value Change Per Share0.100.4%0.100.4%0.090.4%0.190.8%0.220.9%
Usd Dividend Per Share0.050.2%0.050.2%0.050.2%0.040.2%0.040.2%
Usd Total Gains Per Share0.150.6%0.150.6%0.130.6%0.241.0%0.261.1%
Usd Price Per Share2.98-2.98-5.41-3.28-2.34-
Price to Earnings Ratio30.84-30.84-52.35-30.25-21.61-
Price-to-Total Gains Ratio19.68-19.68-40.63-24.17-24.17-
Price to Book Ratio1.98-1.98-3.83-2.41-1.72-
Price-to-Total Gains Ratio19.68-19.68-40.63-24.17-24.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.32994
Number of shares300
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.04
Usd Book Value Change Per Share0.100.19
Usd Total Gains Per Share0.150.24
Gains per Quarter (300 shares)45.4971.42
Gains per Year (300 shares)181.97285.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16311917254232276
2127237354107464562
3190356536161696848
42544747182149281134
531759390026811611420
6381711108232113931706
7444830126437516251992
8507948144642918572278
95711067162848220892564
106341186181053623212850

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Nanjing Well Pharmaceutical Co Ltd

About Nanjing Well Pharmaceutical Co Ltd

Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables. The company also provides synthetic base oils, such as hydraulic fluids, lubricity additives for metals, metal quenching, base fluids and lubricity additives, synthetic base for compress lubricants, synthetic base oil for gear, base oil of chain lubricants, base stock of engine oil, base stock of heat transfer oil, and base oil of grease; and other products, including painting and coating, textile chemicals, field chemicals, and low foam metal cleaners. In addition, it engages in the manufacturing of bio-based materials; research and development, production, and sales of feed additives; technology research and development of bio-based materials; and research and development, and manufacturing of electronic special materials, as well as technical development, technical consultation, and technical services. The company also exports its products to Europe, the United States, Southeast Asia, and internationally. The company was formerly known as Nanjing Well Pharmaceutical Co.,Ltd. and changed its name to Nanjing Well Pharmaceutical Group Co.,Ltd. in April 2020. Nanjing Well Pharmaceutical Group Co.,Ltd. was founded in 2000 and is based in Nanjing, China.

Fundamental data was last updated by Penke on 2024-04-18 12:27:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Nanjing Well Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nanjing Well Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Nanjing Well Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 8.6% means that ¥0.09 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nanjing Well Pharmaceutical Co Ltd:

  • The MRQ is 8.6%. The company is making a profit. +1
  • The TTM is 8.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.6%TTM8.6%0.0%
TTM8.6%YOY9.7%-1.2%
TTM8.6%5Y12.1%-3.5%
5Y12.1%10Y12.7%-0.6%
1.1.2. Return on Assets

Shows how efficient Nanjing Well Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nanjing Well Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.4% Return on Assets means that Nanjing Well Pharmaceutical Co Ltd generated ¥0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nanjing Well Pharmaceutical Co Ltd:

  • The MRQ is 4.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.4%TTM4.4%0.0%
TTM4.4%YOY5.5%-1.1%
TTM4.4%5Y7.7%-3.3%
5Y7.7%10Y9.4%-1.7%
1.1.3. Return on Equity

Shows how efficient Nanjing Well Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nanjing Well Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.4% Return on Equity means Nanjing Well Pharmaceutical Co Ltd generated ¥0.06 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nanjing Well Pharmaceutical Co Ltd:

  • The MRQ is 6.4%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 6.4%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.4%TTM6.4%0.0%
TTM6.4%YOY7.3%-0.9%
TTM6.4%5Y10.0%-3.6%
5Y10.0%10Y12.4%-2.4%

1.2. Operating Efficiency of Nanjing Well Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nanjing Well Pharmaceutical Co Ltd is operating .

  • Measures how much profit Nanjing Well Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nanjing Well Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 10.9% means the company generated ¥0.11  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nanjing Well Pharmaceutical Co Ltd:

  • The MRQ is 10.9%. The company is operating less efficient.
  • The TTM is 10.9%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ10.9%TTM10.9%0.0%
TTM10.9%YOY11.7%-0.9%
TTM10.9%5Y14.0%-3.1%
5Y14.0%10Y15.6%-1.6%
1.2.2. Operating Ratio

Measures how efficient Nanjing Well Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.62 means that the operating costs are ¥1.62 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Nanjing Well Pharmaceutical Co Ltd:

  • The MRQ is 1.618. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.618. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.618TTM1.6180.000
TTM1.618YOY1.594+0.024
TTM1.6185Y1.543+0.076
5Y1.54310Y1.513+0.030

1.3. Liquidity of Nanjing Well Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nanjing Well Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.81 means the company has ¥0.81 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Nanjing Well Pharmaceutical Co Ltd:

  • The MRQ is 0.811. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.811. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.811TTM0.8110.000
TTM0.811YOY1.099-0.289
TTM0.8115Y1.887-1.076
5Y1.88710Y1.858+0.029
1.3.2. Quick Ratio

Measures if Nanjing Well Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nanjing Well Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.26 means the company can pay off ¥0.26 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nanjing Well Pharmaceutical Co Ltd:

  • The MRQ is 0.262. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.262. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.262TTM0.2620.000
TTM0.262YOY0.346-0.084
TTM0.2625Y0.730-0.467
5Y0.73010Y0.736-0.006

1.4. Solvency of Nanjing Well Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nanjing Well Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nanjing Well Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.31 means that Nanjing Well Pharmaceutical Co Ltd assets are financed with 30.7% credit (debt) and the remaining percentage (100% - 30.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nanjing Well Pharmaceutical Co Ltd:

  • The MRQ is 0.307. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.307. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.307TTM0.3070.000
TTM0.307YOY0.248+0.059
TTM0.3075Y0.230+0.077
5Y0.23010Y0.239-0.010
1.4.2. Debt to Equity Ratio

Measures if Nanjing Well Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nanjing Well Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 44.3% means that company has ¥0.44 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nanjing Well Pharmaceutical Co Ltd:

  • The MRQ is 0.443. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.443. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.443TTM0.4430.000
TTM0.443YOY0.330+0.113
TTM0.4435Y0.304+0.139
5Y0.30410Y0.319-0.015

2. Market Valuation of Nanjing Well Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Nanjing Well Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Nanjing Well Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 30.84 means the investor is paying ¥30.84 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nanjing Well Pharmaceutical Co Ltd:

  • The EOD is 34.401. Based on the earnings, the company is overpriced. -1
  • The MRQ is 30.837. Based on the earnings, the company is overpriced. -1
  • The TTM is 30.837. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD34.401MRQ30.837+3.564
MRQ30.837TTM30.8370.000
TTM30.837YOY52.350-21.513
TTM30.8375Y30.252+0.585
5Y30.25210Y21.609+8.643
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nanjing Well Pharmaceutical Co Ltd:

  • The EOD is -26.171. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -23.459. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -23.459. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-26.171MRQ-23.459-2.711
MRQ-23.459TTM-23.4590.000
TTM-23.459YOY-21.471-1.989
TTM-23.4595Y93.100-116.560
5Y93.10010Y66.500+26.600
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nanjing Well Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Nanjing Well Pharmaceutical Co Ltd:

  • The EOD is 2.205. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.977. Based on the equity, the company is underpriced. +1
  • The TTM is 1.977. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.205MRQ1.977+0.228
MRQ1.977TTM1.9770.000
TTM1.977YOY3.830-1.854
TTM1.9775Y2.407-0.430
5Y2.40710Y1.719+0.688
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Nanjing Well Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7160.7160%0.630+14%1.402-49%1.563-54%
Book Value Per Share--10.94210.9420%10.226+7%8.893+23%7.383+48%
Current Ratio--0.8110.8110%1.099-26%1.887-57%1.858-56%
Debt To Asset Ratio--0.3070.3070%0.248+24%0.230+34%0.239+28%
Debt To Equity Ratio--0.4430.4430%0.330+34%0.304+46%0.319+39%
Dividend Per Share--0.3830.3830%0.334+15%0.324+18%0.309+24%
Eps--0.7010.7010%0.748-6%0.793-11%0.769-9%
Free Cash Flow Per Share---0.922-0.9220%-1.824+98%-0.835-9%-0.526-43%
Free Cash Flow To Equity Per Share--0.2680.2680%-1.303+587%0.174+53%0.188+43%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---15.912--------
Intrinsic Value_10Y_min---22.350--------
Intrinsic Value_1Y_max---1.001--------
Intrinsic Value_1Y_min---1.614--------
Intrinsic Value_3Y_max---3.459--------
Intrinsic Value_3Y_min---5.420--------
Intrinsic Value_5Y_max---6.464--------
Intrinsic Value_5Y_min---9.822--------
Market Cap3268143263.040+10%2930398484.1602930398484.1600%5306690181.440-45%3221489884.096-9%2301064202.926+27%
Net Profit Margin--0.0860.0860%0.097-12%0.121-29%0.127-33%
Operating Margin--0.1090.1090%0.117-7%0.140-22%0.156-30%
Operating Ratio--1.6181.6180%1.594+2%1.543+5%1.513+7%
Pb Ratio2.205+10%1.9771.9770%3.830-48%2.407-18%1.719+15%
Pe Ratio34.401+10%30.83730.8370%52.350-41%30.252+2%21.609+43%
Price Per Share24.130+10%21.63021.6300%39.170-45%23.782-9%16.987+27%
Price To Free Cash Flow Ratio-26.171-12%-23.459-23.4590%-21.471-8%93.100-125%66.500-135%
Price To Total Gains Ratio21.959+10%19.68419.6840%40.625-52%24.173-19%24.173-19%
Quick Ratio--0.2620.2620%0.346-24%0.730-64%0.736-64%
Return On Assets--0.0440.0440%0.055-19%0.077-43%0.094-53%
Return On Equity--0.0640.0640%0.073-12%0.100-36%0.124-48%
Total Gains Per Share--1.0991.0990%0.964+14%1.725-36%1.872-41%
Usd Book Value--204571744.874204571744.8740%191187185.407+7%166243229.553+23%138001765.355+48%
Usd Book Value Change Per Share--0.0990.0990%0.087+14%0.193-49%0.216-54%
Usd Book Value Per Share--1.5101.5100%1.411+7%1.227+23%1.019+48%
Usd Dividend Per Share--0.0530.0530%0.046+15%0.045+18%0.043+24%
Usd Eps--0.0970.0970%0.103-6%0.109-11%0.106-9%
Usd Free Cash Flow---17238047.224-17238047.2240%-34107690.786+98%-15602775.822-9%-9828071.274-43%
Usd Free Cash Flow Per Share---0.127-0.1270%-0.252+98%-0.115-9%-0.073-43%
Usd Free Cash Flow To Equity Per Share--0.0370.0370%-0.180+587%0.024+53%0.026+43%
Usd Market Cap451003770.300+10%404394990.814404394990.8140%732323245.039-45%444565604.005-9%317546860.004+27%
Usd Price Per Share3.330+10%2.9852.9850%5.405-45%3.282-9%2.344+27%
Usd Profit--13113963.68013113963.6800%13989088.228-6%14814792.181-11%14152374.975-7%
Usd Revenue--153319474.144153319474.1440%143838216.404+7%126175820.734+22%114818803.643+34%
Usd Total Gains Per Share--0.1520.1520%0.133+14%0.238-36%0.258-41%
 EOD+5 -3MRQTTM+0 -0YOY+19 -165Y+11 -2410Y+12 -23

3.2. Fundamental Score

Let's check the fundamental score of Nanjing Well Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1534.401
Price to Book Ratio (EOD)Between0-12.205
Net Profit Margin (MRQ)Greater than00.086
Operating Margin (MRQ)Greater than00.109
Quick Ratio (MRQ)Greater than10.262
Current Ratio (MRQ)Greater than10.811
Debt to Asset Ratio (MRQ)Less than10.307
Debt to Equity Ratio (MRQ)Less than10.443
Return on Equity (MRQ)Greater than0.150.064
Return on Assets (MRQ)Greater than0.050.044
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Nanjing Well Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.843
Ma 20Greater thanMa 5022.367
Ma 50Greater thanMa 10021.740
Ma 100Greater thanMa 20023.597
OpenGreater thanClose23.620
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Working Capital  137,607486,708624,315-431,396192,918-150,92341,996-151,731-109,736



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,138,160
Total Liabilities655,756
Total Stockholder Equity1,480,292
 As reported
Total Liabilities 655,756
Total Stockholder Equity+ 1,480,292
Total Assets = 2,138,160

Assets

Total Assets2,138,160
Total Current Assets470,285
Long-term Assets1,667,875
Total Current Assets
Cash And Cash Equivalents 99,828
Short-term Investments 1,106
Net Receivables 151,137
Inventory 165,129
Other Current Assets 30,264
Total Current Assets  (as reported)470,285
Total Current Assets  (calculated)447,464
+/- 22,821
Long-term Assets
Property Plant Equipment 1,481,663
Intangible Assets 93,529
Other Assets 23,889
Long-term Assets  (as reported)1,667,875
Long-term Assets  (calculated)1,599,081
+/- 68,794

Liabilities & Shareholders' Equity

Total Current Liabilities580,021
Long-term Liabilities75,735
Total Stockholder Equity1,480,292
Total Current Liabilities
Short Long Term Debt 360,453
Accounts payable 124,541
Other Current Liabilities 65,929
Total Current Liabilities  (as reported)580,021
Total Current Liabilities  (calculated)550,923
+/- 29,098
Long-term Liabilities
Long term Debt 40,000
Capital Lease Obligations Min Short Term Debt16,384
Other Liabilities 19,351
Deferred Long Term Liability 1,333
Long-term Liabilities  (as reported)75,735
Long-term Liabilities  (calculated)77,069
+/- 1,333
Total Stockholder Equity
Common Stock135,478
Retained Earnings 443,363
Total Stockholder Equity (as reported)1,480,292
Total Stockholder Equity (calculated)578,841
+/- 901,450
Other
Capital Stock135,478
Common Stock Shares Outstanding 135,478
Net Debt 300,626
Net Invested Capital 1,880,745
Net Tangible Assets 1,386,763
Net Working Capital -109,736
Property Plant and Equipment Gross 1,481,663



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
600,234
725,521
808,198
1,458,271
1,636,416
1,841,427
2,138,160
2,138,1601,841,4271,636,4161,458,271808,198725,521600,234
   > Total Current Assets 
256,651
319,391
318,252
823,299
500,548
464,691
470,285
470,285464,691500,548823,299318,252319,391256,651
       Cash And Cash Equivalents 
73,342
75,735
40,437
180,932
75,559
66,263
99,828
99,82866,26375,559180,93240,43775,73573,342
       Short-term Investments 
0
0
0
90,314
196,711
26,238
1,106
1,10626,238196,71190,314000
       Net Receivables 
109,543
132,142
152,795
167,365
80,033
120,215
151,137
151,137120,21580,033167,365152,795132,142109,543
       Inventory 
64,334
94,395
100,881
114,888
115,045
142,442
165,129
165,129142,442115,045114,888100,88194,39564,334
       Other Current Assets 
9,432
17,119
24,088
18,757
15,540
23,377
30,264
30,26423,37715,54018,75724,08817,1199,432
   > Long-term Assets 
343,583
406,130
489,947
634,971
1,135,868
1,376,735
1,667,875
1,667,8751,376,7351,135,868634,971489,947406,130343,583
       Property Plant Equipment 
234,801
305,301
369,319
500,654
940,803
1,211,713
1,481,663
1,481,6631,211,713940,803500,654369,319305,301234,801
       Intangible Assets 
43,139
42,408
42,483
80,142
78,491
77,481
93,529
93,52977,48178,49180,14242,48342,40843,139
       Other Assets 
65,643
58,421
78,144
54,176
76,574
47,541
23,889
23,88947,54176,57454,17678,14458,42165,643
> Total Liabilities 
156,246
192,725
193,588
217,055
336,754
456,012
655,756
655,756456,012336,754217,055193,588192,725156,246
   > Total Current Liabilities 
145,937
176,396
180,645
198,984
307,629
422,696
580,021
580,021422,696307,629198,984180,645176,396145,937
       Short Long Term Debt 
62,000
85,000
94,761
102,217
90,127
171,193
360,453
360,453171,19390,127102,21794,76185,00062,000
       Accounts payable 
60,520
71,229
59,298
68,853
168,440
144,339
124,541
124,541144,339168,44068,85359,29871,22960,520
       Other Current Liabilities 
10,939
6,696
8,606
9,523
15,594
70,937
65,929
65,92970,93715,5949,5238,6066,69610,939
   > Long-term Liabilities 
10,309
16,329
12,943
18,071
29,125
33,317
75,735
75,73533,31729,12518,07112,94316,32910,309
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
13,598
16,384
16,38413,59800000
       Other Liabilities 
10,188
16,329
12,943
18,071
17,712
19,719
19,351
19,35119,71917,71218,07112,94316,32910,188
> Total Stockholder Equity
443,615
532,796
614,610
1,241,215
1,299,662
1,382,706
1,480,292
1,480,2921,382,7061,299,6621,241,215614,610532,796443,615
   Common Stock
45,756
50,000
50,000
93,333
130,667
135,478
135,478
135,478135,478130,66793,33350,00050,00045,756
   Retained Earnings 
305,607
98,439
180,253
268,361
326,808
388,978
443,363
443,363388,978326,808268,361180,25398,439305,607
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 0000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,088,715
Cost of Revenue-809,662
Gross Profit279,052279,052
 
Operating Income (+$)
Gross Profit279,052
Operating Expense-967,091
Operating Income121,624-688,039
 
Operating Expense (+$)
Research Development57,439
Selling General Administrative35,400
Selling And Marketing Expenses-
Operating Expense967,09192,839
 
Net Interest Income (+$)
Interest Income559
Interest Expense-14,101
Other Finance Cost-2,692
Net Interest Income-16,234
 
Pretax Income (+$)
Operating Income121,624
Net Interest Income-16,234
Other Non-Operating Income Expenses-
Income Before Tax (EBT)108,623121,624
EBIT - interestExpense = -14,101
94,749
108,849
Interest Expense14,101
Earnings Before Interest and Taxes (EBIT)-122,724
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax108,623
Tax Provision-15,460
Net Income From Continuing Ops93,16493,164
Net Income94,749
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-16,234
 

Technical Analysis of Nanjing Well Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nanjing Well Pharmaceutical Co Ltd. The general trend of Nanjing Well Pharmaceutical Co Ltd is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nanjing Well Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nanjing Well Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 26.96 < 27.23 < 27.88.

The bearish price targets are: 23.82 > 22.68 > 20.03.

Tweet this
Nanjing Well Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nanjing Well Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nanjing Well Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nanjing Well Pharmaceutical Co Ltd. The current macd is 0.38762576.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nanjing Well Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Nanjing Well Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Nanjing Well Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Nanjing Well Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartNanjing Well Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nanjing Well Pharmaceutical Co Ltd. The current adx is 17.78.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Nanjing Well Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Nanjing Well Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nanjing Well Pharmaceutical Co Ltd. The current sar is 21.01.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Nanjing Well Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nanjing Well Pharmaceutical Co Ltd. The current rsi is 64.84. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Nanjing Well Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartNanjing Well Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nanjing Well Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nanjing Well Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Nanjing Well Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartNanjing Well Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nanjing Well Pharmaceutical Co Ltd. The current cci is 238.44.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Nanjing Well Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartNanjing Well Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nanjing Well Pharmaceutical Co Ltd. The current cmo is 40.10.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Nanjing Well Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartNanjing Well Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nanjing Well Pharmaceutical Co Ltd. The current willr is -7.14285714.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Nanjing Well Pharmaceutical Co Ltd Daily Williams %R ChartNanjing Well Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nanjing Well Pharmaceutical Co Ltd.

Nanjing Well Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nanjing Well Pharmaceutical Co Ltd. The current atr is 0.9174302.

Nanjing Well Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartNanjing Well Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nanjing Well Pharmaceutical Co Ltd. The current obv is 9,663,121.

Nanjing Well Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartNanjing Well Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nanjing Well Pharmaceutical Co Ltd. The current mfi is 67.41.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Nanjing Well Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartNanjing Well Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nanjing Well Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Nanjing Well Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nanjing Well Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.843
Ma 20Greater thanMa 5022.367
Ma 50Greater thanMa 10021.740
Ma 100Greater thanMa 20023.597
OpenGreater thanClose23.620
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nanjing Well Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Nanjing Well Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nanjing Well Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nanjing Well Pharmaceutical Co Ltd

I send you an email if I find something interesting about Nanjing Well Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Nanjing Well Pharmaceutical Co Ltd.

Receive notifications about Nanjing Well Pharmaceutical Co Ltd in your mailbox!